Literature DB >> 24999314

A fabricated siRNA nanoparticle for ultra-long gene silencing in vivo.

Seung Koo Lee1, Ching-Hsuan Tung1.   

Abstract

Persistent gene silencing is crucially required for the successful therapeutics of short interfering RNA (siRNA). Here, we describe a nanoparticle based delivery system which assembled by layering siRNAs between protease degradable polypeptides to extend the therapeutic window. These tightly packed nanoparticles are efficiently taken up by cells by endocytosis, and the fabricated siRNAs are gradually released following intracellular degradation of the polypeptide layers. During cell division, the particles are distributed to the daughter cells. Due to the slow degradation through the multiple layers, the particles continuously release siRNA in all cells. Using this controlled release construct, the in vivo gene silencing effect of siRNA is consistent for an ultra-long period of time (>3 weeks) with only a single treatment.

Entities:  

Keywords:  gene silencing; gold nanoparticles; in vivo; poly-L-lysine; siRNA

Year:  2013        PMID: 24999314      PMCID: PMC4078887          DOI: 10.1002/adfm.201202777

Source DB:  PubMed          Journal:  Adv Funct Mater        ISSN: 1616-301X            Impact factor:   18.808


  35 in total

Review 1.  Lessons from Nature: microRNA-based shRNA libraries.

Authors:  Kenneth Chang; Stephen J Elledge; Gregory J Hannon
Journal:  Nat Methods       Date:  2006-09       Impact factor: 28.547

2.  Multilayer mediated forward and patterned siRNA transfection using linear-PEI at extended N/P ratios.

Authors:  Sumit Mehrotra; Ilsoon Lee; Christina Chan
Journal:  Acta Biomater       Date:  2009-01-19       Impact factor: 8.947

3.  SiRNA-loaded multi-shell nanoparticles incorporated into a multilayered film as a reservoir for gene silencing.

Authors:  Xin Zhang; Anna Kovtun; Carlos Mendoza-Palomares; Mustapha Oulad-Abdelghani; Florence Fioretti; Simon Rinckenbach; Didier Mainard; Matthias Epple; Nadia Benkirane-Jessel
Journal:  Biomaterials       Date:  2010-05-21       Impact factor: 12.479

4.  Slow release and delivery of antisense oligonucleotide drug by self-assembled peptide amphiphile nanofibers.

Authors:  Selma Bulut; Turan S Erkal; Sila Toksoz; Ayse B Tekinay; Turgay Tekinay; Mustafa O Guler
Journal:  Biomacromolecules       Date:  2011-07-07       Impact factor: 6.988

5.  Influence of nano-carrier architecture on in vitro siRNA delivery performance and in vivo biodistribution: polyplexes vs micelleplexes.

Authors:  Dana J Gary; Hoyoung Lee; Rahul Sharma; Jae-Sung Lee; Youngwook Kim; Zheng Yun Cui; Di Jia; Valorie D Bowman; Paul R Chipman; Lei Wan; Yi Zou; Guangzhao Mao; Keunchil Park; Brittney-Shea Herbert; Stephen F Konieczny; You-Yeon Won
Journal:  ACS Nano       Date:  2011-04-06       Impact factor: 15.881

6.  Multilayer coating of gold nanoparticles with drug-polymer coadsorbates.

Authors:  Nico Reum; Claudia Fink-Straube; Tobias Klein; Rolf W Hartmann; Claus-Michael Lehr; Marc Schneider
Journal:  Langmuir       Date:  2010-10-21       Impact factor: 3.882

Review 7.  Gold nanoparticles for biology and medicine.

Authors:  David A Giljohann; Dwight S Seferos; Weston L Daniel; Matthew D Massich; Pinal C Patel; Chad A Mirkin
Journal:  Angew Chem Int Ed Engl       Date:  2010-04-26       Impact factor: 15.336

8.  Smart multilayered assembly for biocompatible siRNA delivery featuring dissolvable silica, endosome-disrupting polycation, and detachable PEG.

Authors:  Tomoya Suma; Kanjiro Miyata; Yasutaka Anraku; Sumiyo Watanabe; R James Christie; Hiroyasu Takemoto; Momoko Shioyama; Noha Gouda; Takehiko Ishii; Nobuhiro Nishiyama; Kazunori Kataoka
Journal:  ACS Nano       Date:  2012-08-08       Impact factor: 15.881

Review 9.  Multilayered polyelectrolyte assemblies as platforms for the delivery of DNA and other nucleic acid-based therapeutics.

Authors:  Christopher M Jewell; David M Lynn
Journal:  Adv Drug Deliv Rev       Date:  2008-03-04       Impact factor: 15.470

Review 10.  Maintaining the silence: reflections on long-term RNAi.

Authors:  Koen Raemdonck; Roosmarijn E Vandenbroucke; Joseph Demeester; Niek N Sanders; Stefaan C De Smedt
Journal:  Drug Discov Today       Date:  2008-08-07       Impact factor: 7.851

View more
  6 in total

1.  Solution Conditions Tune and Optimize Loading of Therapeutic Polyelectrolytes into Layer-by-Layer Functionalized Liposomes.

Authors:  Santiago Correa; Natalie Boehnke; Elad Deiss-Yehiely; Paula T Hammond
Journal:  ACS Nano       Date:  2019-04-18       Impact factor: 15.881

Review 2.  Progress and perspective of inorganic nanoparticle-based siRNA delivery systems.

Authors:  Ying Jiang; Shuaidong Huo; Joseph Hardie; Xing-Jie Liang; Vincent M Rotello
Journal:  Expert Opin Drug Deliv       Date:  2016-01-14       Impact factor: 6.648

3.  Versatile Nanodelivery Platform to Maximize siRNA Combination Therapy.

Authors:  Seung Koo Lee; Benedict Law; Ching-Hsuan Tung
Journal:  Macromol Biosci       Date:  2016-09-22       Impact factor: 4.979

4.  Layer-by-layer nanoparticles for systemic codelivery of an anticancer drug and siRNA for potential triple-negative breast cancer treatment.

Authors:  Zhou J Deng; Stephen W Morton; Elana Ben-Akiva; Erik C Dreaden; Kevin E Shopsowitz; Paula T Hammond
Journal:  ACS Nano       Date:  2013-10-21       Impact factor: 15.881

5.  An authentic imaging probe to track cell fate from beginning to end.

Authors:  Seung Koo Lee; Luke J Mortensen; Charles P Lin; Ching-Hsuan Tung
Journal:  Nat Commun       Date:  2014-10-17       Impact factor: 14.919

6.  Composite vector formulation for multiple siRNA delivery as a host targeting antiviral in a cell culture model of hepatitis C virus (HCV) infection.

Authors:  E Crouchet; R Saad; C Affolter-Zbaraszczuk; J Ogier; T F Baumert; C Schuster; F Meyer
Journal:  J Mater Chem B       Date:  2017-01-09       Impact factor: 7.571

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.